Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 3
1957 4
1958 2
1959 1
1960 2
1963 2
1965 2
1966 2
1967 2
1968 8
1969 9
1970 10
1971 4
1972 8
1973 11
1974 12
1975 12
1976 10
1977 9
1978 22
1979 13
1980 12
1981 15
1982 12
1983 7
1984 11
1985 17
1986 37
1987 14
1988 6
1989 12
1990 9
1991 4
1992 10
1993 13
1994 14
1995 18
1996 14
1997 22
1998 28
1999 20
2000 19
2001 14
2002 20
2003 17
2004 17
2005 26
2006 30
2007 33
2008 29
2009 54
2010 46
2011 67
2012 66
2013 50
2014 48
2015 67
2016 70
2017 58
2018 72
2019 60
2020 86
2021 89
2022 112
2023 103
2024 98
2025 85

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,701 results

Results by year

Filters applied: . Clear all
Page 1
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.
Kobayashi K, Ogasawara S, Maruta S, Okubo T, Itokawa N, Haga Y, Seko Y, Moriguchi M, Watanabe S, Shiko Y, Takatsuka H, Kanzaki H, Koroki K, Inoue M, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Suzuki E, Ooka Y, Nakamoto S, Inaba Y, Ikeda M, Okabe S, Morimoto N, Itoh Y, Nakamura K, Ito K, Azemoto R, Atsukawa M, Itobayashi E, Kato N. Kobayashi K, et al. Among authors: inaba y. Clin Cancer Res. 2023 Dec 1;29(23):4760-4769. doi: 10.1158/1078-0432.CCR-23-1462. Clin Cancer Res. 2023. PMID: 37796614
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Kodama Y, Ueshima K, Moriguchi M, Inaba Y, Yamashita T, Iwamoto H, Ueno M, Ogasawara S, Kuzuya T, Kodama T, Sato Y, Tada T, Tsuchiya K, Nishiofuku H, Yamakado K, Sone M, Ikeda M, Takehara T, Hamano T, Kudo M. Kodama Y, et al. Among authors: inaba y. BMC Cancer. 2025 Mar 11;25(1):434. doi: 10.1186/s12885-025-13648-5. BMC Cancer. 2025. PMID: 40069616 Free PMC article.
Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.
Shoji M, Kato H, Koshizaka M, Kaneko H, Baba Y, Ishikawa T, Teramoto N, Kinoshita D, Yamaguchi A, Maeda Y, Inaba Y, Shiko Y, Ozawa Y, Bohr VA, Maezawa Y, Yokote K. Shoji M, et al. Among authors: inaba y. Aging Cell. 2025 Aug;24(8):e70093. doi: 10.1111/acel.70093. Epub 2025 Jun 3. Aging Cell. 2025. PMID: 40459998 Free PMC article. Clinical Trial.
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS collaborators. Furuta S, et al. Among authors: inaba y. Ann Rheum Dis. 2024 Jan 2;83(1):96-102. doi: 10.1136/ard-2023-224343. Ann Rheum Dis. 2024. PMID: 37734880 Clinical Trial.
Serum IgG4-negative autoimmune pancreatitis.
Kamisawa T, Takuma K, Tabata T, Inaba Y, Egawa N, Tsuruta K, Hishima T, Sasaki T, Itoi T. Kamisawa T, et al. Among authors: inaba y. J Gastroenterol. 2011 Jan;46(1):108-16. doi: 10.1007/s00535-010-0317-2. Epub 2010 Sep 8. J Gastroenterol. 2011. PMID: 20824290
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer management.
Goto Y, Urabe F, Ogihara Y, Nakata M, Nakano J, Fujiwara K, Hashimoto M, Koike Y, Iwamoto Y, Miyajima K, Fukuokaya W, Iwatani K, Imai Y, Inaba Y, Ito K, Yanagisawa T, Murakami M, Tashiro K, Watanabe K, Miki J, Kimura T; JIKEI‐YAYOI Collaborative Group. Goto Y, et al. Among authors: inaba y. BJU Int. 2025 Jul 19. doi: 10.1111/bju.16860. Online ahead of print. BJU Int. 2025. PMID: 40682449
Sodium-glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database.
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Maezawa Y, Shiko Y, Inaba Y, Kawasaki Y, Kashiwagi Y, Kawakami E, Yamamoto S, Yokote K. Ishibashi R, et al. Among authors: inaba y. J Diabetes Investig. 2024 Sep;15(9):1231-1238. doi: 10.1111/jdi.14253. Epub 2024 Jun 14. J Diabetes Investig. 2024. PMID: 38874094 Free PMC article.
1,701 results